Conference Presentations
-
Keynote : Address
Mark McClellan, MD, PhD
Robert J. Margolis Professor of Business, Medicine, and Policy, and Director , Margolis Center for Health Policy at Duke University,
-
Presentation 1 : Current Value Frameworks – What’s New?
-
Presentation 1 : Current Value Frameworks – What’s New?
Presentation
Patrick Gleason, PharmD
PharmD, Senior Director of Health Outcomes, Prime Therapeutics,
-
Presentation 1 : Current Value Frameworks – What’s New?
Presentation
Rick Chapman, PhD, MS
PhD, MS, Director of Health Economics, Institute for Clinical and Economic Review (ICER),
-
Presentation 1 : Current Value Frameworks – What’s New?
-
Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework
Presentation
Jeroen Jansen, PhD
PhD, Lead Scientific Advisor of the Open Source Value Project (OSVP), Innovation and Value Initiative,
-
Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework
-
Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework
Presentation
Lou Garrison, PhD
PhD, Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute (School of Pharmacy), University of Washington,
-
Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework
-
Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework
-
Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework
Presentation
Charles Phelps, PhD
PhD, University Professor and Provost Emeritus, University of Rochester, Gualala, CA, USA,
-
Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework
Presentation
Reed Johnson, PhD
PhD, Professor of Medicine, Duke Clinical Research Institute, Duke University,
-
Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework
Presentation
Robert Dubois, MD, PhD
MD, PhD, Chief Science Officer & Executive Vice President, National Pharmaceutical Council (NPC),
-
Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework
-
Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework
-
Presentation 4 : Specific Value Assessment Considerations
-
Presentation 4 : Specific Value Assessment Considerations
Presentation
Patricia Danzon, PhD
PhD, Celia Moh Professor Emeritus, Health Care Management Department, The Wharton School, University of Pennsylvania,
-
Presentation 4 : Specific Value Assessment Considerations